The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG

Björn Ställberg, Pedro Teixeira, Coert Blom, Karin Lisspers, Ioanna Tsiligianni, Rachel Jordan, Miguel Román-Rodríguez, Nanne Kleefstra, Oleksii Korzh, David Price, Niels Chavannes

Research output: Contribution to journalArticle

3 Downloads (Pure)

Abstract

Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality with high social and economic costs. The prevalence of COPD has been reported to vary between 6 and 26.1% worldwide.1 COPD has also been associated with a high prevalence of one or more comorbid conditions, which have an impact on health status and mortality.2,​3,​4,​5 Although several diseases have been studied as COPD comorbidities6,7 few studies have looked at the issue of multimorbidity in COPD.8,​9,​10

COPD, like other chronic disorders, has been associated with comorbidities that increase in number and severity with age, and are more prevalent among deprived social groups.5,8 There is evidence that comorbidities increase the risk for exacerbations, reduce health status, and increase the risk of mortality.5,8 COPD guidelines (e.g., GOLD recommendations) still consider the diagnosis and management of comorbidities from an individual disease point of view.11 Consequently, health services focus on individual diseases rather than multimorbidity.10,​11,​12,​13 A better knowledge of the prevalence and impact of multimorbidity facing COPD patients in primary care would help to evaluate whether a different approach (i.e., multimorbidity) should be taken.

Research on the prevalence of comorbidities among patients with COPD and their impact on health status in primary care patients is scarce. Most studies that evaluated the spectrum and prevalence of comorbidities affecting COPD patients have been conducted in secondary care settings. For example, Divo et al.4 found a relationship between comorbidities and the risk of death over 51 months. Anxiety, cancers, and heart diseases are among the most significant comorbid diseases associated with COPD mortality risk in secondary care settings.4 Increasing knowledge about COPD comorbidities in primary care is essential for the development of better intervention strategies and for reframing clinical guidelines.

This is a unique opportunity to evaluate the impact of individual comorbidities and multimorbidity on COPD patients in primary care in different settings.
Original languageEnglish
Article number16069
Journalnpj Primary Care Respiratory Medicine
Volume26
DOIs
Publication statusPublished - 17 Nov 2016

Fingerprint

Chronic Obstructive Pulmonary Disease
Health Status
Comorbidity
Primary Health Care
Secondary Care
Guidelines
Mortality
Health Services
Heart Diseases
Anxiety
Economics
Morbidity
Costs and Cost Analysis

Keywords

  • chronic obstructive pulmonary disease
  • medical research

Cite this

The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients : a protocol for an UNLOCK study from the IPCRG. / Ställberg, Björn; Teixeira, Pedro; Blom, Coert; Lisspers, Karin; Tsiligianni, Ioanna; Jordan, Rachel ; Román-Rodríguez, Miguel; Kleefstra, Nanne; Korzh, Oleksii ; Price, David; Chavannes, Niels.

In: npj Primary Care Respiratory Medicine, Vol. 26, 16069, 17.11.2016.

Research output: Contribution to journalArticle

Ställberg, Björn ; Teixeira, Pedro ; Blom, Coert ; Lisspers, Karin ; Tsiligianni, Ioanna ; Jordan, Rachel ; Román-Rodríguez, Miguel ; Kleefstra, Nanne ; Korzh, Oleksii ; Price, David ; Chavannes, Niels. / The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients : a protocol for an UNLOCK study from the IPCRG. In: npj Primary Care Respiratory Medicine. 2016 ; Vol. 26.
@article{b2e3f4463dac4738a908c364d388b202,
title = "The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG",
abstract = "Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality with high social and economic costs. The prevalence of COPD has been reported to vary between 6 and 26.1{\%} worldwide.1 COPD has also been associated with a high prevalence of one or more comorbid conditions, which have an impact on health status and mortality.2,​3,​4,​5 Although several diseases have been studied as COPD comorbidities6,7 few studies have looked at the issue of multimorbidity in COPD.8,​9,​10COPD, like other chronic disorders, has been associated with comorbidities that increase in number and severity with age, and are more prevalent among deprived social groups.5,8 There is evidence that comorbidities increase the risk for exacerbations, reduce health status, and increase the risk of mortality.5,8 COPD guidelines (e.g., GOLD recommendations) still consider the diagnosis and management of comorbidities from an individual disease point of view.11 Consequently, health services focus on individual diseases rather than multimorbidity.10,​11,​12,​13 A better knowledge of the prevalence and impact of multimorbidity facing COPD patients in primary care would help to evaluate whether a different approach (i.e., multimorbidity) should be taken.Research on the prevalence of comorbidities among patients with COPD and their impact on health status in primary care patients is scarce. Most studies that evaluated the spectrum and prevalence of comorbidities affecting COPD patients have been conducted in secondary care settings. For example, Divo et al.4 found a relationship between comorbidities and the risk of death over 51 months. Anxiety, cancers, and heart diseases are among the most significant comorbid diseases associated with COPD mortality risk in secondary care settings.4 Increasing knowledge about COPD comorbidities in primary care is essential for the development of better intervention strategies and for reframing clinical guidelines.This is a unique opportunity to evaluate the impact of individual comorbidities and multimorbidity on COPD patients in primary care in different settings.",
keywords = "chronic obstructive pulmonary disease, medical research",
author = "Bj{\"o}rn St{\"a}llberg and Pedro Teixeira and Coert Blom and Karin Lisspers and Ioanna Tsiligianni and Rachel Jordan and Miguel Rom{\'a}n-Rodr{\'i}guez and Nanne Kleefstra and Oleksii Korzh and David Price and Niels Chavannes",
note = "Funding The IPCRG provided funding for this research project as an UNLOCK Group study for which the funding was obtained through an unrestricted grant by Novartis AG, Basel, Switzerland. Novartis has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study will include data from the Optimum Patient Care Research Database, and is undertaken in collaboration with Optimum Patient Care and the Respiratory Effectiveness Group, which will provide the data for this initiative without charge to the UNLOCK Group.",
year = "2016",
month = "11",
day = "17",
doi = "10.1038/npjpcrm.2016.69",
language = "English",
volume = "26",
journal = "npj Primary Care Respiratory Medicine",
issn = "2055-1010",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients

T2 - a protocol for an UNLOCK study from the IPCRG

AU - Ställberg, Björn

AU - Teixeira, Pedro

AU - Blom, Coert

AU - Lisspers, Karin

AU - Tsiligianni, Ioanna

AU - Jordan, Rachel

AU - Román-Rodríguez, Miguel

AU - Kleefstra, Nanne

AU - Korzh, Oleksii

AU - Price, David

AU - Chavannes, Niels

N1 - Funding The IPCRG provided funding for this research project as an UNLOCK Group study for which the funding was obtained through an unrestricted grant by Novartis AG, Basel, Switzerland. Novartis has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study will include data from the Optimum Patient Care Research Database, and is undertaken in collaboration with Optimum Patient Care and the Respiratory Effectiveness Group, which will provide the data for this initiative without charge to the UNLOCK Group.

PY - 2016/11/17

Y1 - 2016/11/17

N2 - Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality with high social and economic costs. The prevalence of COPD has been reported to vary between 6 and 26.1% worldwide.1 COPD has also been associated with a high prevalence of one or more comorbid conditions, which have an impact on health status and mortality.2,​3,​4,​5 Although several diseases have been studied as COPD comorbidities6,7 few studies have looked at the issue of multimorbidity in COPD.8,​9,​10COPD, like other chronic disorders, has been associated with comorbidities that increase in number and severity with age, and are more prevalent among deprived social groups.5,8 There is evidence that comorbidities increase the risk for exacerbations, reduce health status, and increase the risk of mortality.5,8 COPD guidelines (e.g., GOLD recommendations) still consider the diagnosis and management of comorbidities from an individual disease point of view.11 Consequently, health services focus on individual diseases rather than multimorbidity.10,​11,​12,​13 A better knowledge of the prevalence and impact of multimorbidity facing COPD patients in primary care would help to evaluate whether a different approach (i.e., multimorbidity) should be taken.Research on the prevalence of comorbidities among patients with COPD and their impact on health status in primary care patients is scarce. Most studies that evaluated the spectrum and prevalence of comorbidities affecting COPD patients have been conducted in secondary care settings. For example, Divo et al.4 found a relationship between comorbidities and the risk of death over 51 months. Anxiety, cancers, and heart diseases are among the most significant comorbid diseases associated with COPD mortality risk in secondary care settings.4 Increasing knowledge about COPD comorbidities in primary care is essential for the development of better intervention strategies and for reframing clinical guidelines.This is a unique opportunity to evaluate the impact of individual comorbidities and multimorbidity on COPD patients in primary care in different settings.

AB - Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality with high social and economic costs. The prevalence of COPD has been reported to vary between 6 and 26.1% worldwide.1 COPD has also been associated with a high prevalence of one or more comorbid conditions, which have an impact on health status and mortality.2,​3,​4,​5 Although several diseases have been studied as COPD comorbidities6,7 few studies have looked at the issue of multimorbidity in COPD.8,​9,​10COPD, like other chronic disorders, has been associated with comorbidities that increase in number and severity with age, and are more prevalent among deprived social groups.5,8 There is evidence that comorbidities increase the risk for exacerbations, reduce health status, and increase the risk of mortality.5,8 COPD guidelines (e.g., GOLD recommendations) still consider the diagnosis and management of comorbidities from an individual disease point of view.11 Consequently, health services focus on individual diseases rather than multimorbidity.10,​11,​12,​13 A better knowledge of the prevalence and impact of multimorbidity facing COPD patients in primary care would help to evaluate whether a different approach (i.e., multimorbidity) should be taken.Research on the prevalence of comorbidities among patients with COPD and their impact on health status in primary care patients is scarce. Most studies that evaluated the spectrum and prevalence of comorbidities affecting COPD patients have been conducted in secondary care settings. For example, Divo et al.4 found a relationship between comorbidities and the risk of death over 51 months. Anxiety, cancers, and heart diseases are among the most significant comorbid diseases associated with COPD mortality risk in secondary care settings.4 Increasing knowledge about COPD comorbidities in primary care is essential for the development of better intervention strategies and for reframing clinical guidelines.This is a unique opportunity to evaluate the impact of individual comorbidities and multimorbidity on COPD patients in primary care in different settings.

KW - chronic obstructive pulmonary disease

KW - medical research

U2 - 10.1038/npjpcrm.2016.69

DO - 10.1038/npjpcrm.2016.69

M3 - Article

VL - 26

JO - npj Primary Care Respiratory Medicine

JF - npj Primary Care Respiratory Medicine

SN - 2055-1010

M1 - 16069

ER -